DANIEL A KOBRINSKI D.O. NPI 1255610473

NPI Information

  • NPI: 1255610473
  • Provider Name: DANIEL A KOBRINSKI, D.O.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 700 3RD ST STE 302
    NEPTUNE BEACH, FL
    ZIP 32266
  • Phone: (904) 997-3800

Map and Directions

Get Directions

NPI Details

Daniel A Kobrinski, D.O. is a hematology and oncology internal medicine in Neptune Beach, FL with 13 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Daniel A Kobrinski, D.O. NPI is 1255610473. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

700 3RD ST STE 302
NEPTUNE BEACH, FL
ZIP 32266-082
Phone: (904) 997-3800
Fax: (904) 997-3899

The NPI 1255610473 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Magnesium level (HCPCS:83735)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Nephelometry, test method using light (HCPCS:83883)
  • Folic acid level, serum (HCPCS:82746)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Phosphate level (HCPCS:84100)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Uric acid level, blood (HCPCS:84550)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Blood creatinine level (HCPCS:82565)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Blood test, clotting time (HCPCS:85610)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Blood potassium level (HCPCS:84132)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic (HCPCS:G2012)

The enumeration date for this NPI number is 8/4/2011 and was last updated on 12/26/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineBF4649604-A981ILLINOISNo
2207RX0202XInternal MedicineMedical OncologyOS15346FLORIDANo
3207RH0003XInternal MedicineHematology & OncologyOS15346FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
14OSWAOTHERFLORIDAFL BLUE
2P02080860OTHERFLORIDARAILROAD MEDICARE
3KD199OTHERFLORIDAMEDICARE
4025064400MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.